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1 Introduction
Protein folding is an intricate process. Proteins
must achieve their native conformation to be fully
functional. Therefore, it is essential to understand
the exact mechanism of protein folding and the
precise effects of various factors/conditions that
could impact the process. Our current understand-
ing of protein folding is predominantly based on in
vitro denaturation/renaturation experiments in-
volving (mostly) purified natural and/or recombi-
nant full-length proteins and/or in silico modeling
studies.The seminal denaturation/renaturation ex-
periments performed by Christian Anfinsen and
his colleagues in the 1950–60s indicated that the
folding code is contained entirely in the amino acid
sequence of the protein [1].Computer-based simu-
lation experiments seemed to corroborate this con-
clusion [2, 3]. Thus, the primary sequence of the
polypeptide is believed to contain both necessary
and sufficient information to specify its unique 3D
structure [1–3]. However, despite obvious progress
in the field and the availability of new technologies
and powerful computers, the protein folding code
still remains undeciphered.
A comprehensive understanding of protein
folding requires elucidation of the protein folding
mechanism under native intracellular conditions.
In vivo protein folding occurs in a crowded cellular
environment and is widely believed to start during
protein synthesis on the ribosome, i.e., co-transla-
tionally [4–6]. Co-translational folding is a vectori-
al process, proceeding step-wise from the N termi-
nus to the C terminus of the nascent polypeptide
chain as it emerges from the ribosome [4–6]. Dur-
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ing this process the nascent polypeptide remains
tethered to the ribosome through its C-terminal
end. It has become clear that numerous events ac-
company protein synthesis and folding on the ribo-
some [4–6]. After its birth at the peptidyl trans-
ferase center (PTC) of the ribosome, the nascent
polypeptide begins its journey “from youth to ma-
turity” through the ribosomal tunnel to the cytosol
to become a functional protein.Almost immediate-
ly after its birth at the PTC, the nascent chain is
subjected to multiple interactions, constraints and
folding events [4–6]. The exit of the nascent chain
out of the ribosome tunnel is often coupled to var-
ious modifications and interactions with export
targeting particles (i.e.,signal recognition particle),
chaperones and/or folding catalysts [4–6].The rate
of protein synthesis is (mostly) modulated by codon
usage in the messenger RNA (mRNA) being trans-
lated, and this actively facilitates the co-transla-
tional folding process and channels it to the most
productive pathway [4].The in vivo protein-folding
process, however, is not 100% efficient. Unproduc-
tive co-translational folding intermediates also
form during protein synthesis.Such aberrant inter-
mediates may undergo enhanced interaction with
quality control systems (e.g.,chaperones) and/or be
subjects of co-translational degradation [7, 8].
In this review, we provide an overview of the
complex co-translational events that accompany
synthesis, maturation, folding and degradation of
nascent polypeptide chains (Fig. 1).
2 Birth of polypeptides via peptide bond
formation at the ribosome PTC
The ribosome is a large nucleoprotein complex that
translates the information contained in an mRNA
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Figure 1. Schematic representation of the
complex co-translational events accompa-
nying synthesis and biogenesis of nascent
polypeptide chains in pro- and eukaryotes.
(A) Events accompanying nascent peptide
growth inside the ribosomal tunnel: co-
translational α-helix formation and co-
translational peptide stalling occur in both
pro- and eukaryotes. (B) Events accompa-
nying nascent peptide growth and matura-
tion in the immediate vicinity of the tunnel
exit: co-translational N-terminal Met re-
moval, co-translational N-terminal acetyla-
tion and co-translational binding to signal
recognition particle (SRP) occur in both
pro- and eukaryotes; co-translational bind-
ing to trigger factor (TF) and co-trans-
lational deformylation are specific to
prokaryotes; co-translational binding to
nascent associated complex (NAC), Ssbs
and co-translational N-terminal myristoyla-
tion are specific for eukaryotes. (C) Events
accompanying nascent peptide growth and
maturation outside the ribosomal tunnel:
co-translational folding and oligomeriza-
tion, co-translational chaperone binding
and co-translational signal peptide cleav-
age occur in both pro- and eukaryotes; 
co-translational N-glycosylation, co-trans-
lational peptide self-cleavage, co-transla-
tional ubiquitination and degradation are
specific for eukaryotes.© 2011 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim 625
to produce the encoded protein [9]. Ribosomes
from all organisms are composed of two subunits.
The small subunit contains the decoding center
that directs pairing of the appropriate aminoacyl-
transfer RNAs (aa-tRNAs) with triplets (codons) in
the mRNA.The large subunit harbors the catalytic
(peptidyl transferase) center that joins the amino
acids together with peptide bonds [9, 10]. In all liv-
ing organisms the translation process involves four
basic steps: initiation, elongation, termination and
ribosome recycling [9–12]. Of these steps, elonga-
tion is the most predominant as it accounts for all
but one of the amino acids in the completed
polypeptide chains [13, 14]. During the initiation
step of protein synthesis the ribosome is positioned
at the AUG codon of the mRNA with the initiator
tRNA (Met-tRNAi) in the peptidyl or P site of the ri-
bosome [13, 14]. This placement sets the reading
frame for all subsequent aa-tRNAs coming into the
A site of the ribosome. The Genetic Code dictates
which aminoacyl-tRNA will then bind to the A site
during the decoding process regulated by the small
ribosomal subunit. Decoding dictated by triplets
(codons) in the mRNA is followed by peptide bond
formation catalyzed by the PTC in the large riboso-
mal subunit. Translation elongation involves se-
quential addition of amino acids to the polypeptide
chain and is facilitated by a set of extremely con-
served elongation factors (for detailed reviews see
[13, 14]).
X-ray structures of the prokaryotic (70S) ribo-
some provided detailed information about the
structure of the PTC and the mechanism of peptide
bond formation [9, 10]. In addition, valuable struc-
tural information has been obtained from cryo-
electron microscopy (cryo-EM) structures of ribo-
somes of both prokaryotic and eukaryotic origin
[15,16].Recent progress in solving the X-ray struc-
tures of the eukaryotic yeast (Saccharomyces cere-
visiae) 80S ribosome [17] and the 40S ribosomal
subunit of the ciliate protozoan Tetrahymena ther-
mophila [18], as well as determination of the cryo-
EM structures of a plant (Triticum aestivum) 80S ri-
bosome, further advances our knowledge in the
field [19, 20].
It is believed that the general mechanism of
peptide bond formation is the same in all kingdoms
of life.The central event in this process is the nu-
cleophilic attack of the amino group of the amino
acid in the A site on the ester carbon of the amino
acid of the peptidyl-tRNA in the P site [9, 10].The
decoding center itself appears to be devoid of
proteins [9, 10], suggesting that ribosomal RNA
(rRNA) directs peptide bond formation, while both
rRNAs and the ribosomal proteins serve as a scaf-
fold for proper positioning of the substrates. It was
proposed that a reactive N3 amine of the conserved
nucleotide A2451 in the rRNA was critical for the
general mechanism of peptide bond formation;how-
ever, this was disproved by recent evidence (for a
review see [9]).Thus,to date,the exact details of the
catalytic mechanism of the PTC remain unknown.
3 The ribosome tunnel
After synthesis at the PTC, polypeptides are be-
lieved to begin traveling through the ribosomal exit
tunnel (or “protein conducting channel”) in the
large ribosomal subunit [21–24]. Detailed insights
into the architecture of the tunnel have been ob-
tained from X-ray and cryo-EM structures of pro-
karyotic and eukaryotic ribosomes (for a review see
[24]).The tunnel is ~80–100 Å long and its diame-
ter varies from ~10 Å at its narrowest region to
~20 Å at its widest region (at the exit site) [24].The
tunnel is expected to cover ~30–40 amino acids of
the elongating polypeptide at a time [21–30] (as-
suming that the polypeptide is in a fully extended
conformation).
While it is widely believed that all nascent
chains pass through the ribosome tunnel, it re-
mains unclear whether this is a strictly true. Some
studies employing, for example, the hot tritium
([3H])-bombardment technique [31] and/or im-
mune electron microscopy [32] detected very short
nascent peptides (from 2 to 42 amino acids in
length) exposed on the surface of ribosomes [31,
32]. However, comparative cross-linking experi-
ments using Escherichia coli ribosomes showed
that with increasing length, nascent peptides be-
come predominantly and progressively cross-
linked to sites within domains V , IV, II, III and I of
the 23S rRNA (which form the ribosome tunnel en-
trance and walls,respectively).These cross-linking
results further suggested that the peptides do pass
through the tunnel [33–36]. Moreover, occasional
exposure of short peptides on the surface of ribo-
somes was proposed to be due to abortion of trans-
lation and subsequent attachment of the released
incomplete chains to the ribosome [33–36].To visu-
alize the nascent chain inside the tunnel one would
require a structure with at least 3.5-Å resolution,
which is not yet available for ribosome-bound nas-
cent chain complexes. However, recent cryo-EM
reconstructions (done at ~6–7-Å resolution) of ri-
bosomes containing nascent chains [24,37–39] pro-
vided intriguing details of the complex interactions
between the nascent chain and the ribosome (see
below).
The ribosome tunnel wall is composed primari-
ly of the negatively charged rRNA (23S in prokary-
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otes and 28S in eukaryotes) and the ribosomal pro-
teins L4, L22 and L23 in prokaryotes and L4, L17
and L25 in eukaryotes [5, 18, 24]. It should be not-
ed, however, that protein contributions to the for-
mation of the tunnel are thought to be limited to the
narrow “constriction” region of about 10–20 Å in
length (~30 Å away from the PTC) and to a ~20–30-
Å-long “lower”region at the exit (“vestibule”) site of
the tunnel ([24] and references therein).The con-
striction region of the tunnel is predominantly
formed by the protruding loops of the L4 and L22
(L17) proteins,whereas the exit site is largely com-
prised of the L23 (L25) protein [5,18,24].The elec-
trostatic potential in the tunnel is mostly negative
[40].
For a long time, it was widely believed that the
ribosomal tunnel merely acts as an inert passage-
way for nascent polypeptide chains [25–28]. How-
ever, emerging evidence indicates that the riboso-
mal tunnel is not a passive conduit, but rather may
actively participate in nascent chain folding [29,30,
40], and in the regulation of protein synthesis via
modulation of PTC activity [41–44]. In this regard,
it is notable that a number of leader peptides have
been shown to induce translational stalling in re-
sponse to cellular stress conditions and/or pres-
ence or absence of effector molecules,thereby pro-
viding a means to regulate expression of down-
stream genes [41–44]. Bacterial SecM,TnaC, RrmC
and MifM are the best known examples of such
regulatory proteins/peptides [41–43]. Below, we
discuss two representative cases (SecM and TnaC).
3.1 Stalling of translation inside the ribosome
tunnel induced by nascent SecM and TnaC
peptides
SecM (secretion monitor) is a 170-amino acid E.coli
protein that regulates expression of the down-
stream SecA (secretion driving) ATPase in the
secM-secA operon [43, 45]. SecA is a central com-
ponent of the translocase in E.coli,which drives the
transmembrane movement of the pre-protein and
its insertion into integral membrane complex, se-
cYEG, the translocon [46]. Expression of secA is
controlled by specific mechanisms that respond to
the protein secretion status of the cell [43,45].SecA
expression is elevated under conditions of compro-
mised translocase activity [43,45].SecM was shown
to play an important role in this event [43,45].SecM
is itself a periplasmic protein and, under normal
conditions, is rapidly degraded after its export to
the periplasm [43, 45]. However, SecM translation
was shown to be subject to regulation via elonga-
tion arrest, which becomes prolonged when export
of nascent SecM is blocked (e.g., due to compro-
mised translocase activity) [43, 45, 47].Thus, SecM
regulates its own co-translational export.
Interestingly, SecM translational arrest was
shown to facilitate secA expression [43, 45, 47]. A
17-amino acid sequence (150-FSTPVWISQAQGI-
RAGP-166) in the C-terminal region of SecM was
found to cause stalling of SecM elongation at
Gly165, thereby producing peptidyl-glycyl-tRNA
bound to the P site [43,45,47].The next codon (en-
coding Pro166) was essential for arrest, suggesting
that prolyl-tRNA acts as an A-site effector of this
event [43, 45]. Translational stalling in this case is
thought to promote remodeling of the secM-secA
mRNA at the intergenic region to expose the
Shine-Dalgarno sequence preceding the secA open
reading frame (ORF), and enhance recruitment of
30S ribosomal subunits and initiation of translation
of the SecA protein [43, 45]. Nine residues within
the SecM arrest sequence (shown in bold type;
150-FXXXXWIXXXXGIRAGP-166) were shown
to be of major importance in modulating the effi-
ciency of SecM translational stalling [47].
The role of the ribosomal tunnel in the SecM
stalling process was highlighted by mutational
analysis of the L4 and L22 proteins and the 
23S rRNA [24, 47, 48]. A number of specific muta-
tions in the protruding loops of L4 and L22 and in
the 23S rRNA (e.g., 23S rRNA nucleotides
A749–A753 and A2058 at the constriction site and
nucleotides A2503 and A2062 at the tunnel en-
trance) were shown to abolish nascent peptide-de-
pendent stalling [47, 48].These results indicate an
active contribution of the components of the ribo-
some tunnel during stalling.
Another example of translational regulation via
nascent peptide-mediated stalling is that con-
trolled by the 24-amino acid E. coli TnaC regulato-
ry peptide [38, 42, 43, 49].The TnaC peptide is pro-
duced from the tnaC ORF located upstream of the
tryptophanase (tnaA) gene in the tna operon of 
E. coli and regulates tryptophanase expression in
response to tryptophan levels in the cell [49].When
levels of free tryptophan are low, the TnaC peptide
is properly translated and terminated.This results
in dissociation of the mRNA and ribosomes, which
allows the Rho factor to access the transcription
termination site and terminate transcription before
the RNA polymerase reaches the downstream
tryptophan-catabolizing genes in the tna operon.
Elevated tryptophan levels lead to ribosome
stalling mediated by TnaC. The stalled complex
masks the Rho-dependent transcription termina-
tion site, thus allowing the transcription of the
downstream tryptophan-catabolizing genes to pro-
ceed [49]. As in the case of SecM, a number of
residues in the TnaC peptide (including Trp12,© 2011 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim 627
Asp16 and Pro24 [49–51]) and in components of the
ribosomal tunnel (L22 protein and 23S rRNA) were
shown to be critical for the stalling process [38,
49–51]. However, it appears that the ribosome may
use different mechanisms to recognize different
stalling peptides [24, 48, 52]. For example, TnaC
translational arrest (in contrast to SecM arrest) was
found to be insensitive to A2503 or A2062 muta-
tions [48].
One of the interesting and yet unresolved ques-
tions in this process is the impact of nascent pep-
tide compaction (i.e., folding) inside the ribosome
tunnel on the stalling mechanism. Fluorescence
resonance energy transfer (FRET) experiments
suggested that the nascent SecM peptide might (at
least in part) acquire a compact α-helical structure
within the tunnel [53]. In contrast, cryo-EM analy-
sis of the 70S ribosome-TnaC complex indicated
that, when inside the tunnel, the TnaC peptide is
predominantly in an extended conformation, al-
though some compaction of the TnaC peptide in the
vestibule region of the tunnel could not be also ex-
cluded [38].
While it is clear that some peptides can direct
translational stalling, the exact nature and mecha-
nism of signal transmission from the stalled pep-
tide to the PTC resulting in translational arrest is
unknown. Cryo-EM of the 70S·TnaC complex at
5.8-Å resolution suggested that communication be-
tween the stalled peptide and the PTC does not in-
volve substantial conformational changes of the
tunnel itself [38]. It was proposed that the “stalling
signal” might propagate back to the PTC through
the nascent chain, via induction of a specific con-
formation within the chain that inhibits the PTC
[53, 54]. Recent evidence indicates that the stalling
sequence(s) may cause impairment of the PTC A
site by changing its conformation, thereby trigger-
ing elongation arrest [44]. These possibilities sug-
gest that the ribosome tunnel might have evolved
to be capable of sensing not only specific amino
acid residues and their location within the nascent
peptide, but also specific conformations of nascent
chains, all of which together dictate the transla-
tional fate of the encoded (downstream) protein(s)
in response to, e.g., environmental cues [24].
Translational control via nascent peptide-medi-
ated stalling is not limited to bacterial systems. For
example, the translation of mRNAs without a stop
codon harboring poly(A) tail in yeast is considered
as an eukaryotic example of nascent peptide-
induced translational arrest caused by a poly(A)-
encoded polylysine stretch at the C terminus of the
proteins, which causes subsequent degradation of
such aberrant proteins by proteasome [55, 56].The
Neurospora crassa arg-2 uORF encoding a 24-
residue arginine attenuator peptide is another ex-
ample of an eukaryotic arrest sequence.This pep-
tide directs stalling of ribosomes at the uORF stop
codon in response to arginine, thereby blocking ri-
bosomes from reaching the ARG-2 initiation codon
under conditions of sufficient arginine [57].ARG-2
encodes arginine-specific carbamoyl phosphate
synthetase, the first enzyme in fungal arginine
biosynthesis.A number of residues within the arg-
2 uORF (Asp12,Tyr13,Lys14,and Trp19) have been
identified as critically important for the stalling
process [57].
In summary,studies of the stalling sequences of
SecM,TnaC and other peptides suggest that the na-
ture of the amino acid residues passing through the
tunnel, the distance of these critical residues from
the PTC,their interaction with the tunnel walls,and
perhaps the conformation of the peptide, may all
play important roles in the regulation of nascent
peptide-mediated translational arrest [24]. The
nascent peptide sequences that have been identi-
fied as directing stalling are portable and are use-
ful tools for studying co-translational protein fold-
ing [6]. Nevertheless, the precise molecular mech-
anisms involved in recognition of the critical nas-
cent peptide sequences and in the execution of
ribosome stalling have yet to be determined. In
addition, the nature and extent of interactions
between the tunnel interior and non-stalling nas-
cent peptide sequences passing through the tunnel
remain unclear.
3.2 Co-translational folding inside the ribosome
tunnel
From cryo-EM studies visualizing stalled peptides
inside the ribosome tunnel [24], it is evident that
the elongating peptide starts to fold very early in its
genesis, perhaps immediately at the PTC (Fig. 1A).
The first theoretical presentation of such a possi-
bility was made by Lim and Spirin in the mid-1980s
[58]. Stereochemical analysis of the transpeptida-
tion reaction allowed them to suggest that the ribo-
some likely generates an α-helical conformation at
the C-terminal end of the nascent peptide [58].The
groups of Arthur Johnson and Carol Deutsch ex-
perimentally verified this hypothesis using FRET
and/or a combination of accessibility assays, re-
spectively [29, 30, 53, 59].There is now ample evi-
dence indicating that peptides can acquire compact
(α-helical) structures in the ribosomal exit tunnel
near the PTC and in the lower ~20–30-Å “vestibule”
region of the tunnel [24,30,39,53,59,60].Moreover,
it has been suggested that the tunnel may actively
modulate peptide secondary structure formation
via induction and stabilization of α-helices within
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regions of the nascent chain with high helix-form-
ing propensity and deferring regions lacking such
propensity from helix formation [53,60].It remains
an open question, however, to what extent the tun-
nel itself may change in conformation,and whether
peptide sequence(s) with strong helix-forming
propensity might be capable of modulating the
width of the tunnel to allow the corresponding
polypeptide stretches to acquire secondary struc-
ture all along the tunnel [60]. It has been suggest-
ed that the “vestibule” (lower) region of the tunnel
may be structurally dynamic and capable of ac-
commodating even higher order (tertiary) struc-
tures [61–63].
4 Interactions and modifications of the
nascent polypeptide chain outside 
the tunnel
The fate of the nascent polypeptide chain (includ-
ing its conformation) outside the ribosome tunnel
is to a substantial extent governed by the ultimate
destination of the protein within the cell (its intra-
cellular compartmentalization and/or secretion) as
well as its modifications. Upon extrusion out of the
tunnel,nascent chains are subjected to subsequent
folding events and interactions with chaperones
and modifying enzymes [5]. As discussed below,
many of these events are thought to take place in
the vicinity of the tunnel exit since many nascent
chain-interacting proteins and enzymes appear to
be associated with the ribosome [5]. Many of the
studies devoted to analysis of nascent chain con-
formation inside the tunnel utilized either model/
fusion sequences and/or fragments of transmem-
brane/secretory proteins, such as fragments of the
vesicular stomatitis virus (VSV) G glycoprotein
and/or voltage-gated potassium (Kv) channel pro-
tein [29, 30, 40, 59, 60, 62]. Segments of the VSV G
glycoprotein that were shown to form α-helices in-
side the tunnel were found to retain their compact
helical structures during their subsequent move-
ment through the translocon [59]. Thus, once
formed, 2-D helical structures within transmem-
brane protein(s) appeared to be retained during
their journey through both the tunnel and the
translocon, thereby facilitating their integration
into the membrane [59].
It should be noted that in both prokaryotes and
eukaryotes, entry of secreted and membrane-
bound proteins into the translocon involves inter-
action of the proteins’ signal peptide with signal
recognition particle (SRP). This is discussed fur-
ther below.
4.1 Interaction of nascent chains with SRP
Proper sorting and compartmentalization of pro-
teins is essential for their functions and for overall
cellular function.For secreted proteins and the ma-
jority of the membrane-bound proteins, this in-
volves interaction of the SRP with (mostly) hy-
drophobic signal sequences (see below) within the
nascent chains as they emerge from the ribosome.
SRP targets nascent polypeptides to the mem-
brane-associated translocation machinery through
association with its membrane receptor(s),thereby
facilitating subsequent export and/or membrane
integration of the polypeptide [64–66].
SRP is a universally conserved ribonucleopro-
tein (RNA-protein complex); however, the size and
structure of the RNA and the number of proteins
involved in SRP formation varies [64–66]. In
prokaryotes, SRP is composed of a single protein
(Ffh) and a small RNA (4.5S). In eukaryotes, SRP
contains six distinct proteins (including SRP54,
which is homologous to Ffh) and a 7S RNA (one do-
main of which shares sequence and structural ho-
mology with the prokaryotic 4.5S RNA) [64–66].
Biochemical and structural studies have identi-
fied the ribosomal protein L23 (L25 in eukaryotes)
as the main determinant of ribosome–SRP interac-
tion [65, 66].This interaction seems to occur inde-
pendently of the nascent peptide in the exit tunnel
of the ribosome [67];however,it accelerates target-
ing of the ribosome nascent chain complex to the
translocon [64–66].The signal peptide is believed to
interact first with the ribosomal proteins L4 and
L22 inside the tunnel, then with L23 at the exit site
of the tunnel, and subsequently with SRP [65].
A recent crystal structure of the Ffh protein bound
to a signal sequence revealed a putative induced-fit
mechanism that leads to accommodation of the sig-
nal sequence within the hydrophobic groove of the
SRP protein [68].Interaction between SRP and the
signal sequence may (as in eukaryotes),or may not
(as in bacteria) temporarily arrest translation of the
nascent chain containing the signal sequence
[64–66].
Following its assembly, the ribosome-nascent
chain-SRP complex is targeted to specific SRP re-
ceptors (e.g.,FtsY in E.coli, which is homologous to
the α-subunit of the eukaryotic receptor),which fa-
cilitates subsequent assembly of the translocon.
A recent cryo-EM structure of the E. coli ribosome
in complex with SRP and the FtsY receptor demon-
strated that the ribosome acts as a platform that op-
timally positions critical SRP regions for receptor
interaction [69].The Ffh component of SRP and the
FtsY SRP receptor are both GTPases and bind GTP
before complex formation [64–66].Multiple distinct© 2011 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim 629
conformations of the SRP–FtsY complex have been
identified that orchestrate the transfer of the ribo-
some-bound SRP complexes to the translocon [70].
An early, GTP-independent complex subsequently
rearranges to an “activated state” complex. Upon
GTP hydrolysis, the SRP complex dissociates and
co-translational translocation of the nascent chain
proceeds [70].
We would like to emphasize that this is a sim-
plified overview of the complex events underlying
co-translational translocation of proteins, and that
many aspects of these processes remain to be elu-
cidated in both prokaryotes and eukaryotes.
Cytosolic nascent chains that do not cross mem-
branes during their maturation and do not interact
with SRP seem to differ in at least certain aspects
of their “life” as compared to secreted and mem-
brane-bound polypeptides. Cytosolic nascent
chains might be expected to start folding into high-
er order 3-D structures almost immediately after
leaving the “vestibule” exit region of the ribosome
tunnel (see below). However, at least some of cy-
tosolic nascent chains have been shown to first in-
teract with ribosome-associated chaperones
and/or other ribosome-associated protein com-
plexes and enzymes [5, 71]. Many of these interac-
tions and consequent events are actually shared
between secreted/transmembrane and cytosolic
proteins [5, 71]. Representative examples are dis-
cussed below.
4.2 The prokaryotic ribosome-associated
chaperone, trigger factor
Trigger factor (TF) is the only ribosome-associated
chaperone indentified to date in bacteria [72].
E. coli TF is a constitutively expressed, ATP-inde-
pendent and abundant chaperone [72].TF has two
major activities, functioning as a peptidyl-prolyl
cis/trans isomerase (PPIase) and as a chaperone
that aids in proper folding of nascent polypeptides
[72].Work showing that TF lacking the entire PPI-
ase domain maintains its chaperone activity in vivo
demonstrated that the PPIase activity of TF is not
required for its chaperone function [73].TF exists
in the cytosol mostly as a dimer, yet interacts with
the ribosome predominantly as a monomer (via
binding to ribosomal protein L23 at the exit site of
the tunnel) [74].Ribosomal protein L29 also partic-
ipates in bridging interactions between the ribo-
some and TF [72, 74]. The X-ray crystallographic
structure of TF has been solved in both its free and
ribosome-bound forms [72, 75]. It should be men-
tioned that the affinity of TF for vacant ribosomes
is rather low (~1 µm),but is greatly increased (up to
~10-fold) in the presence of a nascent polypeptide
[72]. Interestingly,TF and SRP can simultaneously
bind to ribosomes [72]. TF binding is abolished,
however,when SRP binds to the SRP receptor FtsY
[72].TF has three domains,which form an elongat-
ed, “dragon”-shaped structure [72, 75]. The N-ter-
minal domain (the “tail” of the structure) contains
the signature “GFRXGXXP” motif, which is neces-
sary and sufficient for interaction of TF with the ri-
bosomal protein L23 [72, 75]. The middle domain
(“head”) of TF is connected to the N-terminal do-
main via a long linker and carries the PPIase activ-
ity. The C-terminal domain is the largest domain
and forms the central chaperone body of TF with
two protruding “arms” on both sides.
Various X-ray and cryo-EM structures of TF
bound to E. coli ribosomes are available and show
the arch-like appearance of TF over the tunnel exit
site [72, 75].This architecture of the complex sug-
gests that the position of TF over the tunnel might
provide additional “protection” to nascent chains
emerging out of the tunnel.TF was proposed to act
as a cradle, aiding in nascent chain co-translation-
al folding [72,75];however,the details of this mech-
anism remain unknown. Cross-linking experi-
ments indicated that TF interacts with the nascent
peptide using the entire interior surface of its arch
[76]. This interior surface is mostly hydrophobic,
with a few polar and charged residues,and is capa-
ble of interacting with a variety of nascent chains
[72, 77].TF binding is dependent on the size of the
nascent chain as well as its sequence composition
and structure (folding state) [72]. The interior
space of the TF arch is of sufficient size to accom-
modate small globular protein fragments, suggest-
ing that co-translational folding of globular do-
mains might occur under the cover of the TF arch,
before the nascent chain reaches the cytosol [72].
TF improves the yield of the correctly folded pro-
teins, especially under stress conditions favoring
misfolding [72]. However, since TF is not an essen-
tial protein [72], it is likely that only a fraction of
emerging nascent polypeptides interact with TF.
Nascent chains that do not require TF to achieve
their proper conformation may do so in a chaper-
one-independent manner or utilize other ‘down-
stream’ chaperones (see further below).
4.3 Eukaryotic Hsp70s/ribosome-associated
complex and the nascent associated complex
Unlike prokaryotes, eukaryotes have more than
one ribosome-associated chaperone [5, 71]. These
have been best characterized in the yeast S. cere-
visiae. Yeast has two distinct ribosome-associated
chaperone machineries: the Ssb/Ssz/Zuotin triad
and the nascent associated complex (NAC) [78–81].
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Both complexes are abundant and conserved
among eukaryotes [78–81].Two components of the
Ssb/Ssz/Zuotin machinery are Hsp70 family mem-
bers: Ssb (represented by Ssb1 and Ssb2) and Ssz.
It also includes Zuotin (Zuo),the Hsp40 co-chaper-
one for Ssz [78–81]. Ssz and Zuo form a stable het-
erodimeric complex known as ribosome-associated
complex (RAC) [80]. RAC acts as co-chaperone for
Ssb and stimulates its ATPase activity via the N-
terminal J domain of Zuo [80]. Ssz cannot bind ri-
bosomes directly,while Ssb can (although the exact
binding site remains unknown) [82]. Zuo bridges
RAC to the ribosome via a charged region at the
Zuo C terminus,which interacts with eukaryotic ri-
bosomal protein L31, located in close proximity to
the tunnel exit site [82].
The RAC complex is well conserved in mam-
mals and consists of Hsp70L1 and Mpp11, ho-
mologs of Ssz and Zou, respectively [83, 84]. RAC
and Ssb form part of the specific eukaryotic chap-
erone network termed “chaperones linked to pro-
tein synthesis” (CLIPS), which cooperates with the
translational apparatus in assisting co-translation-
al folding of proteins [85]. However, not all ribo-
some-associated CLIPS are capable of interacting
with growing nascent chains. Neither Zuo1 nor
Ssz1 can interact with nascent chains; thus, this
property seems to be limited (in the triad) to Ssbs
[85].
The second largest eukaryotic ribosome-associ-
ated chaperone complex is NAC. NAC is also well
conserved in eukaryotes [81]. It is an ATP-inde-
pendent heterodimeric protein complex composed
of α and β subunits.Both the α and β subunits were
shown to interact with nascent polypeptides; how-
ever,only the β subunit is involved in NAC interac-
tion with the ribosome [81].A conserved positively
charged [RRK(X)nKK] ribosome-binding motif
was identified within the β subunit of NAC that is
essential for NAC complex attachment to the ribo-
somal protein L25 [81].This N-terminal ribosome-
binding domain is sufficient and necessary to tar-
get NAC to the ribosome.Mutations in the β subunit
and in L25 reduce and/or abolish NAC binding to
the ribosome in vivo and in vitro [81].Therefore,ri-
bosomal proteins L23 and L25 appear to function
as universal docking sites for ribosome-associated
factors and complexes seeking access to the nas-
cent chains in prokaryotes and eukaryotes,respec-
tively [5].
NAC was originally (and is still) considered to
be the first eukaryotic nascent chain-interacting
protein that binds elongating nascent polypeptides
as they are being translated [86].NAC was also sug-
gested to shield nascent chains from the cytosol
[87]. NAC depletion exposed very short nascent
polypeptide chains (~12 amino acids) to proteolysis
[87], while under normal circumstances (NAC
present), only longer nascent chains (more than
30–40 amino acids) were susceptible to proteolytic
digestion on the ribosome [25, 26, 87]). Based on
these findings, NAC was proposed to, at least in
part,contribute to the formation of the tunnel walls
[87], perhaps in the “vestibule” region. However,
this hypothesis did not find any further experi-
mental support.The observations that NAC associ-
ates with ribosomes and interacts with nascent
chains led to the suggestion that NAC may actively
participate in the folding of newly synthesized
polypeptides [86, 87]. This also remains to be
proven.
NAC is not essential in yeast; however, its dele-
tion leads to embryonic lethality in mice, nema-
todes,and fruit flies [81].It was proposed that NAC
controls the co-translational targeting of nascent
peptides to the endoplasmic reticulum (ER) by reg-
ulating the accessibility of the nascent chains to
SRP [81]. Nevertheless, to a substantial extent, the
role of NAC in eukaryotic translation remains enig-
matic.
4.4 Other nascent chain interacting chaperones
It should be noted that interactions with nascent
chains as they emerge out of the ribosome tunnel
are not only limited to ribosome-associated chap-
erones and protein complexes such as those de-
scribed above. Members of chaperone networks
downstream of the ribosome-associated TF and/or
Ssb-RAC/NAC complexes have also been shown to
interact with nascent chains and facilitate their
folding [5, 88]. In particular, members of both the
Hsp70 (DnaK,DnaJ in bacteria) and Hsp60 (GroEL
in bacteria) chaperone families were found to in-
teract co-translationally with elongating nascent
chains [5, 88, 89].These types of interactions, how-
ever, are expected to occur on a “need-basis”, as in
the case of the majority of proteins that undergo
enhanced interaction with Hsp70/Hsp60 family
members. Indeed, it appears that not only produc-
tive protein folding, but also misfolding, can occur
co-translationally (see below).
Finally, in eukaryotes, nascent chains are also
subject to co-translational interaction with en-
zymes of the protein disulfide isomerase family,
which catalyze disulfide bond formation, reduc-
tion, and isomerization, as well as members of the
quality control/calnexin chaperone system that is
directed toward (Asn-linked glycosylated) secreted
glycoproteins [90].© 2011 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim 631
4.5 Co-translational protein modifications 
by ribosome-bound enzymes
The fate of nascent polypeptide chains is not only
governed by their interaction with ribosome-asso-
ciated ribonucleoprotein particles and nascent as-
sociated complexes and chaperones. Various pro-
tein modifications are known to affect protein fold-
ing, stability, activity, intracellular localization, and
interaction with binding partners. Many of the en-
zymes involved in these modifications are associat-
ed with ribosomes (Fig. 1B) and are capable of act-
ing on elongating nascent chains [5, 71].We review
a number of representative examples below.
4.5.1 Co-translational deformylation of N-terminal
formylmethionine
In eubacteria, mitochondria and chloroplasts, pro-
tein translation is initiated by a specialized transfer
RNA charged with formylmethionine (tRNAfMet)
[91]. Formylation of the N-terminal methionine
blocks the reactive amino group and prevents un-
favorable side reactions [91], thus enhancing the
efficiency of translation initiation. Peptide de-
formylase (PDF) removes the N-terminal formyl
group as soon as the nascent chain emerges from
the ribosomal tunnel [92, 93]. It is the first ribo-
some-associated protein/enzyme that acts upon
nascent chains in bacteria, mitochondria and
chloroplasts [92–94]. PDFs are metalloproteases
that have been shown to adopt a unique fold
[92–94].X-ray analysis of the complex between the
positively charged PDF C-terminal helix (that re-
cruits PDF to the ribosome) and the 70S E. coli ri-
bosome suggested a model in which PDF and TF
act synergistically to enable deformylation in the
shielded environment provided by TF [93]. PDF is
thought to bind in the groove between ribosomal
proteins L22 and L32, with L22 serving as the ma-
jor docking site [93]. It has been proposed that po-
sitioning of the PDF C-terminal helix in the groove
orients the enzyme’s active site toward the riboso-
mal tunnel exit [93]. PDFs are essential enzymes
and their activities are indispensable for cellular
function [92, 94].
4.5.2 Removal of N-terminal methionine
Deformylation of the N-terminal methionine of
nascent peptides is often followed in eubacteria by
co-translational removal of the N-terminal methio-
nine itself by methionine aminopeptidase (MetAP
or MAP) [95,96].However,this process (also called
N-terminal methionine excision, NME) is not lim-
ited to bacterial systems and is well conserved
across all kingdoms of life [95, 96]. More than 50%
of all cellular proteins are expected to undergo 
N-terminal methionine removal [95,96].Surveys of
N-terminal sequences and in vitro experiments
utilizing model peptide substrates have shown that
the N-terminal methionine is removed if the fol-
lowing (second) residue is small and uncharged
(e.g., Met, Gly,Ala, Ser,Thr, Pro,Val or Cys) [95, 96].
MAPs are ubiquitous and essential enzymes in
all living organisms [95,96].Based on their domain
structure, MAPs are classified as type I or type II
[95,96].Eubacteria contain only type I MAPs,while
eukaryotes contain both types. Type I enzymes
have been further subdivided into type Ia and type
Ib subclasses, depending on the presence or ab-
sence of an N-terminal extension that contains zinc
finger motif(s) [95, 96]. This N-terminal extension
was suggested (and experimentally proven in the
case of yeast MAP1) to aid MAP recruitment to the
ribosome [97, 98]. There are, however, relatively
few data on the interaction between MAPs and ri-
bosomes. Given their function, it is likely that
MAPs (at least type Ia) bind to ribosomes in a way
that positions the enzyme close to the ribosome
tunnel exit.
4.5.3 Nα-terminal acetylation
Acetylation is the most common co-translational
protein modification [99, 100]. Approximately 60%
of yeast proteins and more than 80% of human
polypeptides are acetylated ([99, 100] and refer-
ences therein). This modification is, however,
rather rare in bacteria and occurs less frequently in
archea [99]. Acetylation occurs through Nα-termi-
nal acetyltransferase (Nat)-mediated transfer of
the acetyl group from acetyl-CoA to the α-amino
group of the protein’s N-terminal amino acid [99,
100]. Eukaryotes contain three major Nats termed
NatA, NatB, and NatC [100]. Each of the three Nats
contains a catalytic subunit and one or two auxil-
iary subunits [100]. NatA is dependent upon the
prior action of MAP and acetylates proteins begin-
ning with Gly,Ala, Ser,Thr and sometimes Val and
Cys [100]. The activities of NatB and NatC are in-
dependent of methionine removal by MAP . NatB is
specific for N-terminal Met-Glu,Met-Asp and Met-
Asn pairs [100]. NatC is specific for proteins start-
ing with Met and having a bulky hydrophobic
amino acid in the second position (Met-Ile, Met-
Leu, Met-Trp and Met-Phe are the most common
substrates) [100].
Extensive studies of Nα-terminal acetylation in
yeast and mammalian systems [101] have shown
that both yeast and mammalian Nats are associat-
ed with ribosomes [102, 103]. Cross-linking exper-
iments in S. cerevisiae revealed NatA association
with the large ribosomal subunit via a NatA auxil-
iary subunit (Nat1p) that anchored the catalytic
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Nat subunit to the 60S ribosome [102,103].In addi-
tion, NatB and NatC were found to be associated
with translating ribosomes [103]. NatA was shown
to interact with ribosomal proteins L25 and L35
and, therefore, also uses the “universal” L25 (L23)
docking site in the vicinity of the ribosome tunnel
exit (as does NAC,see above) [102,103].L35 is also
expected to be in close proximity to the tunnel exit
[17, 18, 22].
Nats are expected to act on nascent chains al-
most immediately as they emerge from the tunnel
exit (nascent chains of ~41–47 amino acids in
length have been shown to be acetylated [99–101]).
However, yeast Nat1p was shown to require longer
nascent polypeptides for interaction than NAC
and/or Ssbs [102]. Interplay between various pro-
teins and protein complexes docking near the tun-
nel exit and the hierarchy of their binding to the ri-
bosome and/or the nascent chains is currently un-
known and represents an interesting and challeng-
ing question to be answered.
Despite its prevalence, the exact biological role
of N-terminal acetylation is unknown [99–101],and
it is likely to have pleiotropic effects. Nat mutants
in yeast exhibit diverse phenotypes,which include,
but are not limited to, slow growth, temperature
sensitivity,osmotic sensitivity,deficiency in utiliza-
tion of nonfermentable carbon sources, inability to
form functional actin cables, etc. [104].Acetylation
of yeast ribosomal proteins was recently shown to
play important roles in the protein synthesis activ-
ity of ribosomes and in the maintenance of transla-
tional fidelity [104]. It was originally suggested
(and widely believed) that N-terminal acetylation
protects proteins from degradation. However, it
was recently shown in S. cerevisiae that N-termi-
nal-acetylated methionine can act as a degradation
signal,targeted by the Doa10 ubiquitin ligase [105].
4.5.4 Nα-terminal myristoylation
Lipid modification of nascent chains can change
protein subcellular localization, direct proteins to
various cellular membranes and/or affect pro-
tein–protein interactions [106]. Myristoylation in-
volves addition of the 14-carbon saturated fatty
(myristic) acid to the N-terminal glycine of proteins
[106]. Myristoylation takes place after removal of
the initiator methionine from the nascent polypep-
tide by a methionyl aminopeptidase.This modifica-
tion can be found in a variety of eukaryotic proteins
of cellular and viral origin [106].The reaction is cat-
alyzed by myristoyl-CoA:protein N-myristoyl-
transferase (NMT) [106]. In vertebrates, there are
two NMT family members,NMT1 and NMT2 [106].
The general consensus sequence recognized by
NMTs at the N terminus of a protein is Gly-X3-X4-
X5-(Ser/Thr/Cys)6 [106].It has been shown that the
~10-kDa N-terminal domain of human NMT is
both necessary and sufficient for recruitment of
NMT to the ribosome [107]. However, the exact
docking site of NMTs on the ribosome surface re-
mains unknown. It is expected that, similar to oth-
er enzymes acting on elongating nascent chains, it
may be positioned in the vicinity of the ribosome
tunnel exit. In addition, while myristoylation was
originally thought to be exclusively a co-transla-
tional protein modification [108],recent reports in-
dicate that it can also occur post-translationally
[107].In this case,it is expected that NMT would act
as a cytosolic factor without involvement of ribo-
some binding. Co-translational modifications of
nascent chains are not limited to those that take
place in the vicinity of the ribosome tunnel exit.
Many downstream modification events in the life of
polypeptide chains (involving longer nascent pep-
tides) are also co-translational (Fig. 1C). As dis-
cussed below, asparagine (N)-linked glycosylation
of polypeptides in the lumen of the ER is an exam-
ple of such a downstream co-translational event
[109].
5 Co-translational N-linked glycosylation
Glycosylation of asparagine residues (N-linked
glycosylation) is one of the most ubiquitous co-
translational covalent modifications of proteins in
the lumen of the ER [109]. This modification in-
volves transfer of oligosaccharides onto secretory
proteins in the ER, which is catalyzed by the het-
ero-oligomeric complex called oligosaccharyl-
transferase (OST) [109]. Mammalian OST is a
membrane protein consisting of seven to eight
nonidentical subunits (reviewed in reference
[110]). OST uses a dolichol pyrophosphate-linked
oligosaccharide precursor as the donor substrate to
transfer a conserved glycan (GlcNAc2Man9Glc3)
moiety to asparagine residues within consensus
glycosylation sites (N-X-T/S) in the target
polypeptide [109, 110]. OST is believed to be adja-
cent and/or associated with the translocon chan-
nel,thereby facilitating co-translational N-glycosy-
lation of nascent chains [109, 110]. It is assumed
that OST acts on the acceptor glycosylation sites as
soon as they become available inside the ER lumen
(i.e., as soon as the site is ~65–75 amino acids away
from the PTC) [109, 110]. Glycosylation increases
the hydrophilicity of nascent chains and,therefore,
prevents potential aggregation of polypeptides
caused by exposure of hydrophobic segments that
are not fully folded.After their transfer to nascent
chains,N-glycans are subject to modification by the© 2011 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim 633
ER-resident enzymes glucosidase I, glucosidase II,
UDP-glucose:glycoprotein glucosyltransferase and
mannosidase(s) [111]. N-Glycan modifications ap-
pear to be critical for nascent chain interaction with
the calnexin chaperone system and for overall
quality control in the ER [111], which ensures pro-
duction of correctly folded polypeptides and pro-
motes ER-associated degradation (ERAD) of
chains that are folded incorrectly [111].It should be
noted that all of these complex events in the ER
take place after the signal peptide contained in se-
cretory proteins is cleaved off. Cleavage of the sig-
nal peptide is also an important event during co-
translational translocation of the prokaryotic se-
cretory proteins [112].
6 Co-translational nascent peptide cleavage
Signal peptides play a pivotal role in directing pro-
teins to their correct cellular and extracellular
compartments (reviewed in reference [112]).
Cleavage of signal peptides is (almost) an indis-
pensable co-translational event during protein ex-
port to the periplasm and/or ER lumen in prokary-
otic and eukaryotic cells, respectively (reviewed in
reference [112]). Although different signal pep-
tides do not generally share any substantial se-
quence homology, they do contain three conserved
regions: a positively charged N-terminal region, a
central hydrophobic region, and a C-terminal hy-
drophilic region in the vicinity of the cleavage site
[112]. A family of membrane-bound signal pepti-
dases (SPases) associated with the translocon(s)
catalyzes signal peptide cleavage. Signal peptidas-
es include type I SPases, which are found in bacte-
ria, the ER, mitochondria, and chloroplasts, and
type II SPases, which are found exclusively in bac-
teria [112]. Bacterial type I and type II SPases are
believed to be monomeric,while eukaryotic SPases
are multimeric [112]. The hydrophobic central re-
gion and the C-terminal hydrophilic region of the
signal peptide are believed to span the membrane
as an α-helix [112].Cleavage is believed to occur on
the periplasmic/ER lumen side of the membrane
[112]. SPases are essential enzymes required for
cell growth and viability [112].
Other co-translational cleavage events may also
accompany maturation of nascent chains. Picor-
navirus polyproteins are well known to be
processed through a cascade of co-translational
and post-translational cleavage reactions [113].Pi-
cornaviruses in particular employ an unusual
mechanism allowing self-cleavage of the peptide
bond between the 2A and 2B segments of the
polyprotein.Specifically,the 2A segment (encoding
the 2A protease) of the polyprotein adopts a con-
formation allowing self-cleavage of the polypep-
tide at the region between the 2A and 2B segments,
which becomes temporally accessible for cleavage
during co-translational folding of the polyprotein
[113].
The examples discussed above clearly demon-
strate that co-translational folding of nascent
polypeptide chains is accompanied by a variety of
complex events leading to protein processing and
maturation, which together contribute to produc-
tion of fully functional proteins.The process of co-
translational protein folding itself will be briefly
reviewed below.
7 Co-translational protein folding
Co-translational folding is assumed to be a univer-
sal feature of protein folding within cells, having
been demonstrated for both complete and incom-
plete nascent polypeptides of prokaryotic and eu-
karyotic origin, including single- and multi-do-
main,single- and multi-subunit,cytosolic,secreted
and membrane proteins [4–6].All levels of protein
organization can be achieved co-translationally
[4–6]. As discussed above, α-helices [29, 30, 53, 59,
60] (but apparently not β-structures due to the re-
strictions of the geometry of the ribosome tunnel
[23]) seem to form immediately at the PTC. Super-
secondary structures, domains, and complete terti-
ary and quaternary structures are formed outside
of the tunnel [4–6]. It cannot, however, be excluded
that some tertiary types of interactions/structures
may form at the vestibule region of the tunnel
[61–63]. Hierarchical condensation of the elongat-
ing nascent polypeptide chain has been considered
to be the most likely mechanism that governs fold-
ing and assembly of native proteins during synthe-
sis in vivo [4–6]. Both steady-state and kinetic/
time-resolved experiments have been extremely
helpful in understanding the mechanism and path-
way of protein folding in vitro (in a test tube);how-
ever, most of the evidence supporting co-transla-
tional folding has come from steady-state experi-
ments (reviewed in reference [4]). In their snap-
shots of “frozen” co-translational intermediates
attached to ribosomes,these studies revealed com-
pactly folded nascent chain fragments ranging in
their level of structural organization from second-
ary structure elements to domains and/or correctly
folded full-length proteins [4–6]. There remains,
however, limited understanding of how rearrange-
ment of various structures during synthesis and co-
translational folding of proteins takes place and
leads to the native state. For example, it is not clear
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whether helices formed inside the ribosomal tun-
nel may undergo conversion into other structures.
Interestingly, peptides with identical sequences
can be found in proteins within both α- and 
β-structural regions [114]. It is apparent that sec-
ondary structure formation in proteins depends on
the local environment [2, 3, 30, 53, 59, 60].The tun-
nel was suggested to favor formation and stabiliza-
tion of α-helices [30,39,53,59,60].Therefore,it has
been proposed that some α-helices formed inside
the tunnel may be destabilized by local interactions
as they emerge from the tunnel, resulting in their
rearrangement into β- and/or other structures [58,
115].This transition may be facilitated by ribosome
pausing (see below), ribosome-associated chaper-
ones, and/or perhaps even the ribosome itself [4,
115–121].Interestingly,both the large (50S) riboso-
mal subunit and the 23S rRNA have been shown to
have chaperone-like activity, in that they facilitate
folding of some proteins from their unfolded states
[116–119]. Specifically, domain V of the E. coli 23S
rRNA was suggested to play an active role in this
process [118]. This domain of the 23S rRNA con-
tributes to formation of the PTC and the tunnel en-
trance [21, 22]. It is therefore possible that certain
parts of the tunnel (perhaps the entrance and
vestibule regions as well as the adjacent surface of
the ribosome) might actively facilitate folding of
some proteins.
Thus,a nascent polypeptide starts to fold imme-
diately after its synthesis at the PTC and then con-
tinues (in a vectorial manner) to assume more com-
plex structures as soon as it exits the tunnel.As dis-
cussed above,a nascent polypeptide may be subject
to multiple interactions and modifications during
co-translational folding, but the protein neverthe-
less successfully reaches its native state.This rais-
es the intriguing question of whether a unique co-
translational protein folding pathway exists. Obvi-
ously, co-translational protein folding has a num-
ber of unique and characteristic features [4–6].
Most importantly, it is a vectorial process that is
coupled to translation elongation [4–6]. Many re-
cent reports [120–123] provide overwhelming sup-
port for the 20 year-old hypothesis stating that
translation elongation rates may provide an active
conjunction of synthesis and folding of proteins by
allowing temporal separation of sequential folding
events [115, 124]. It should be noted, however, that
non-uniform elongation was also suggested to
modulate mRNA stability [125] and control protein
expression levels [126, 127].
7.1 Non-uniformity of translation rates,
synonymous codon usage and temporal
separation of co-translational folding events
Rates of nascent chain elongation are not uniform
(reviewed in reference [4]).Translation was shown
to proceed more rapidly at some mRNA regions
than others (reviewed in reference [4]).The initial
evidence demonstrating discontinuous elongation
rates came from the seminal publications by Mor-
ris and colleagues, who showed that eukaryotic
(globin) and prokaryotic (MS2 phage coat) proteins
were translated at rates that were not constant
[128, 129]. Subsequently, this phenomenon has
been demonstrated for numerous proteins from
various organisms [4,130].Chaney and Morris first
proposed mRNA secondary structure as the pri-
mary cause of non-uniform translation [129].They
attributed translation pause sites observed during
the synthesis of the MS2 phage coat protein to com-
plex MS2 RNA secondary structure (i.e., hairpin
mRNA regions causing movement of the ribosome
to slow down [129]).However,it became clear from
later studies that,in most of cases,mRNA structure
is not the primary cause of translation non-unifor-
mity. Rather, it was found that the distribution of
codons with different usage frequencies along an
mRNA specifies local rates of translation [4]. This
was subsequently shown to also explain translation
pausing in the case of the MS2 coat protein [131].
Careful analysis of the impact of RNA structure has
demonstrated that after translational initiation
(particularly in eukaryotes), the ribosome can, in
most cases,locally destabilize secondary structures
and move along the message without any signifi-
cant delays [132]. On the other hand, very complex
secondary structures (e.g., those involving pseudo-
knots) can stall elongating ribosomes, resulting in
frameshifts or significant reductions in protein ex-
pression levels [133, 134]. Neverthless, non-uni-
form rates of translation are generally accepted to
originate primarily from non-uniform usage of
synonymous codons along mRNAs.
Notably,the genetic code is degenerate and syn-
onymous codons are utilized with different fre-
quencies and a strong codon bias exists within any
given organism [135]. Moreover, the abundance of
cognate tRNAs is directly proportional to the fre-
quency of codon usage in a given organism [136].
This correlation implies that frequently used
codons will be translated more rapidly than infre-
quently used codons and vice versa. Therefore, a
cluster of rare codons is expected to slow down ri-
bosome movement on the mRNA and lead to a
translational pause [4].© 2011 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim 635
It has been proposed that modulation of trans-
lation elongation rates along an mRNA might serve
to fine tune the co-translational folding of the nas-
cent polypeptide chain, ensuring its high accuracy
and efficiency [115, 124]. Translational pauses
might thus serve as interpunctuations temporally
separating co-translational folding events [4, 115,
120–124]. We have recently reviewed [4] evidence
in support of this hypothesis, which in the past
5 years has attracted an increasing number of pro-
ponents [4, 115, 120–124]. Notably, synonymous
codons are distributed along mRNAs non-random-
ly,and have been identified in clusters at certain re-
gions that are believed to be crucial for protein
folding [4, 115, 120–124]. In a family of structurally
homologous proteins, this distribution of rare
codons along mRNAs appeared to be well con-
served despite differences in codon biases between
the organisms [4, 137].This supports the possibili-
ty that the kinetics of protein translation may play
a substantial role in the in vivo folding process and
serve as a kinetic guide for co-translational folding
[4]. Translation pauses were proposed to separate
synthesis of different secondary structures [115],in
particular, providing a time delay that might allow
and facilitate conversion of α-helices, originally
formed inside the ribosomal tunnel, into other
structures, and further also provide a time delay
necessary for independent folding of larger folding
units such as domains (reviewed in reference [4]).
The importance of synonymous codon usage and
the kinetics of protein translation have been
demonstrated in experiments showing that both
artificial synonymous codon substitutions and nat-
urally occurring silent single nucleotide polymor-
phisms can alter protein folding and conformation
[4, 138, 139]. In addition, when constructs for het-
erologous protein expression were adjusted to uti-
lize codon frequencies along the mRNA, similar to
that observed naturally, the resulting amount of
correctly folded soluble proteins increased [140,
141].Variations in the usage of synonymous codons
and in the abundance of corresponding tRNAs are
also observed between different cell and tissue
types in multicellular organisms [142]. This pres-
ents the possibility of cell/tissue type-specific
adaptation of codon usage along an mRNA to
achieve translation kinetics that are optimal for
correct protein expression and folding in different
cell/tissue types [142]. Interestingly, a bias in the
abundance of different tRNAs was also observed in
a unicellular organism (E. coli) at different growth
rates [143].This was proposed to reflect a mecha-
nism for ensuring efficient and differential expres-
sion of mRNAs utilizing different synonymous
codons at different stages of cellular growth [143].
Such adaptation may also contribute to ensuring
correct protein folding.
The importance of synonymous codon usage
and translation pausing is not limited to temporal
separation of folding events. Ribosome pausing
may also facilitate co-translational binding of co-
factors (such as, e.g., heme) [130, 144, 145] and fa-
cilitate integration of transmembrane segments of
membrane proteins into membranes [144, 146]. In
addition, as mentioned above, non-uniform codon
clustering may help protect mRNAs from degrada-
tion [125].
Taken together, these observations strongly
suggest that mRNAs contain an additional layer of
information beyond their amino acid sequence [4]
and that the genetic code might not be as redun-
dant as originally thought.This is supported by the
finding that not all synonymous codon substitu-
tions are neutral and silent [147].
8 Co-translational protein degradation
Cells have numerous sophisticated mechanisms to
control the quality of newly synthesized proteins,
many of which operate co-translationally [111,
148]. One such mechanism is co-translational pro-
tein degradation [7, 8]. As mentioned above, co-
translational N-terminal acetylation can mark pro-
teins for degradation [105].Nascent chains can also
undergo co-translational ubiquitination and sub-
sequent degradation by the proteasome [7,8].It has
been estimated that 20–55% of newly synthesized
nascent polypeptide chains bearing an N-terminal
degradation signal (“N-degron”) are degraded co-
translationally [8]. The high frequency (~55%) of
co-translational degradation reported for some
polypeptides might have resulted, at least in part,
from experimental conditions such as use of artifi-
cial reporter constructs (heterologous fusion pro-
teins) and cells (S. cerevisiae) overexpressing
Ubr1p, the E3 ubiquitin ligase [8]. E3 ubiquitin lig-
ases are primarily responsible for recognition of N-
degron [149]. Interestingly, it was recently shown
that another yeast E3 ubiquitin ligase, Ltn1, which
acts in the quality control of proteins produced
from non-stop mRNA (see above), may associate
with 60S ribosomes [150]. It is reasonable to sug-
gest that under normal circumstances only a small
fraction of nascent chains (<10%) are subjects of
co-translational degradation [7]. Overall, many as-
pects of the mechanism(s) that couple protein syn-
thesis and degradation remain unknown. The
“translasome”, a protein complex containing pro-
teasomes and many components of the translation
machinery (including ribosomal proteins and initi-
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ation and elongation factors), was recently discov-
ered and suggested to actively couple protein syn-
thesis, quality control and degradation [151].
The occurrence of co-translational degradation
of nascent chains indicates that non-productive in-
termediates arise during co-translational folding.
Therefore, productive co-translational pathway(s)
may be in kinetic competition with pathways that
target nascent chains for degradation. This sug-
gests that co-translational folding intermediates
are populated and that there may thus be a number
of co-translational folding pathways leading to the
native state.It is possible that modulation of the ki-
netics of translation by synonymous codon usage
may help nascent chains follow the most produc-
tive pathway.
9 Conclusions
We have provided a brief overview of the complex
co-translational events accompanying biogenesis
of nascent polypeptide chains (Fig. 1). We believe
that future studies should focus on characteriza-
tion of the dynamic nature of folding intermediates
that arise along the co-translational pathway and
on analysis of the mechanism(s) of their structural
inter-conversions as they mature.
In addition,it should be a priority to learn more
about the active role that mRNA codon usage ap-
pears to play in coordinating protein synthesis and
folding and in guiding co-translational folding to-
wards the most productive pathway. Recent evi-
dence clearly indicates that synonymous codon
substitutions are not random and are subjects to
constraints [4, 147]. Moreover, synonymous codon
substitutions were shown to be associated with
various diseases [152]. Therefore, studies of co-
translational folding and the impact of synony-
mous codon substitutions on this process are of
immense importance for our understanding of the
general mechanism of protein folding as well as
the origin of many diseases. Improved under-
standing of these effects could ultimately impact
personalized medicine and personalized drug
treatment and development programs. Such
knowledge could also aid in appropriate choice of
synonymous codons for codon-optimized gene
variants to be used in gene therapy and/or in the
design of new proteins to be used in biotechnolo-
gy industry.
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